CARDIA INNOVATION AB
Cardia Innovation AB is a biotechnology company that Manufacturs CarbonAid and CarbonMini, CO2 diffusers.
CARDIA INNOVATION AB
Industry:
Biotechnology
Website Url:
http://www.cardiainnovation.com
Status:
Active
Technology used in webpage:
Smelink
Current Employees Featured
Official Site Inspections
http://www.cardiainnovation.com
- Host name: 138.68.100.204
- IP address: 138.68.100.204
- Location: Frankfurt am Main Germany
- Latitude: 50.1188
- Longitude: 8.6843
- Timezone: Europe/Berlin
- Postal: 60313
More informations about "Cardia Innovation AB"
Cardia Innovation AB - Crunchbase Company Profile & Funding
Cardia Innovation AB is a biotechnology company that Manufacturs CarbonAid and CarbonMini, CO2 diffusers.See details»
Contact - Cardia Innovation
Cardia Innovation AB. Månskärsvägen 10 B 141 75 Kungens Kurva Sweden. Kontakt. Phone: +46 (0)70 496 27 20 E-mail: [email protected]@cardiainnovation.comSee details»
Cardia Innovation AB - LinkedIn
Cardia Innovation AB | 50 followers on LinkedIn. Manufacturer of CarbonAid and CarbonMini, CO2 diffusers | Cardia Innovation AB is a biotechnology company based out of Stockholm, …See details»
Cardia Innovation AB - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Cardia Innovation AB of Kungens Kurva, Stockholm. Get the latest business insights from Dun & …See details»
Product Information - Cardia Innovation
The CarbonAid ® and the CarbonMini ® CO 2 diffusers are intended for the insufflation of CO 2 into the thoracic cavity during cardiothoracic surgery, to reduce the risk of air embolism. They …See details»
Cardia Innovation AB - Drug pipelines, Patents, Clinical trials
Explore Cardia Innovation AB with its drug pipeline, therapeutic area, technology platform, .See details»
Cardia Company Profile 2024: Valuation, Funding & Investors
Cardia General Information Description. Developer of transcatheter septal occluders intended to help with congenital cardiac defects lead happy and healthy lives. The company's devices are …See details»
CarbonAid® and CarbonMini® CO2 Diffuser - Artivion
Product Highlights . Persson M. et al. (2003) De-airing of a Cardiothoracic Wound Cavity Model With Carbon Dioxide: Theory and Comparison of a Gas Diffuser With Conventional Tubes. J …See details»
FI PT SLO Navodila za uporabo CArBonAid Co diffuser instruCtions …
E-mail: [email protected], website: www.cardiainnovation.com. The product is protected by the following patents, held by Cardia Innovation AB Patent#US6494858B1, …See details»
CardiAI Company Profile 2024: Valuation, Funding & Investors
Information on valuation, funding, cap tables, investors, and executives for CardiAI. Use the PitchBook Platform to explore the full profile.See details»
Cardia, Inc. - VentureRadar
Similar Companies: Scientia Vascular USA Privately Held Scientia Vascular, a Salt Lake City, UT-based commercial company, is offering a suite of interventional medical devices. By …See details»
CarbonAid - Cardia Innovation
CarbonAid® CO 2 diffuser is a disposable device intended for the insufflation of CO 2 into the open cardiothoracic wound cavity to reduce the risk of air embolism during open heart surgery. …See details»
Revolutionizing Cardiovascular Care: The Next Generation of …
Feb 8, 2024 In the ever-evolving landscape of medicine, the field of interventional cardiology (IC) is driving forward with ground-breaking advances, offering new hope for patients with cardiac …See details»
This Cardiac Device Could Possibly Be the Game Changer That …
Dec 21, 2021 Photo by Jesse Orrico on Unsplash The following post was written and/or published as a collaboration between Benzinga’s in-house sponsored content team …See details»
CardiAI Uses AI To Detect The Signs Of Heart Disease | Amii
Feb 1, 2022 Dr Anmol Kapoor has seen countless patients pass through his office throughout his medical career. However, it was one man in particular that changed the Calgary-based …See details»
CarbonMini - Cardia Innovation
CarbonMini® CO 2 diffuser is a disposable device intended for the insufflation of CO 2 into the cardiothoracic wound to reduce the risk of air embolism. CarbonMini® is designed for wounds …See details»
Innovative heart research has potential to save millions of …
Mar 9, 2021 With major funding from Genome Canada and partnership with Roche Diagnostics International, Heart Institute researchers now poised to tackle an important health issue …See details»
Co-creating the future of cardiovascular care in Canada
Dec 9, 2021 The impact of COVID-19 only increased the burden of cardiovascular disease (CVD) on our healthcare system: a World Health Organization study [i] found severe global …See details»
CardiAI | Top Canada Medtech Company-2022 - Medicaltechoutlook
Dr. Anmol S. Kapoor MD, FRCPC, Founder & CEO Access to clean and actionable data is vital for healthcare professionals to deliver better patient care. With the power of data—delivered …See details»